ProfileGDS4718 / 235116_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 8% 17% 14% 17% 6% 9% 6% 12% 8% 15% 17% 10% 12% 7% 19% 15% 16% 8% 9% 20% 14% 12% 13% 9% 11% 12% 9% 3% 11% 8% 17% 12% 13% 12% 8% 12% 9% 11% 16% 9% 11% 13% 14% 10% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.713368
GSM549102patient 115, normal, homogenized [OPG study]4.0426317
GSM549104patient 119, normal, homogenized [OPG study]3.8877814
GSM549108patient 138, normal, homogenized [OPG study]4.076417
GSM549119patient 077, normal, homogenized [OPG study]3.609746
GSM549133patient 032, cancer, homogenized [OPG study]3.690859
GSM549139patient 042, cancer, homogenized [OPG study]3.616556
GSM549099patient 107, normal, homogenized [OPG study]3.8712312
GSM549109patient 139, normal, homogenized [OPG study]3.74878
GSM549110patient 046, normal, homogenized [OPG study]3.976215
GSM549114patient 063, normal, homogenized [OPG study]3.9894417
GSM549122patient 082, normal, homogenized [OPG study]3.7723110
GSM549134patient 033, cancer, homogenized [OPG study]3.8452712
GSM549136patient 036, cancer, homogenized [OPG study]3.63737
GSM549140patient 044, cancer, homogenized [OPG study]4.0736419
GSM549111patient 047, normal, homogenized [OPG study]3.9299915
GSM549113patient 057, normal, homogenized [OPG study]3.9645816
GSM549132patient 031, cancer, homogenized [OPG study]3.690258
GSM549137patient 038, cancer, homogenized [OPG study]3.734359
GSM549142patient 047, cancer, homogenized [OPG study]4.2263920
GSM549100patient 110, normal, homogenized [OPG study]3.9289614
GSM549107patient 135, normal, homogenized [OPG study]3.825212
GSM549115patient 068, normal, homogenized [OPG study]3.8585313
GSM549116patient 072, normal, homogenized [OPG study]3.746259
GSM549120patient 078, normal, homogenized [OPG study]3.827511
GSM549131patient 030, cancer, homogenized [OPG study]3.8122312
GSM549118patient 074, normal, homogenized [OPG study]3.763479
GSM549129patient 027, cancer, homogenized [OPG study]3.520623
GSM549123patient 088, normal, homogenized [OPG study]3.8288511
GSM549124patient 006, cancer, homogenized [OPG study]3.726318
GSM549126patient 015, cancer, homogenized [OPG study]4.0341817
GSM549128patient 025, cancer, homogenized [OPG study]3.8234812
GSM549103patient 117, normal, homogenized [OPG study]3.935513
GSM549117patient 073, normal, homogenized [OPG study]3.8522412
GSM549138patient 041, cancer, homogenized [OPG study]3.672468
GSM549141patient 045, cancer, homogenized [OPG study]3.7988812
GSM549130patient 028, cancer, homogenized [OPG study]3.76429
GSM549101patient 111, normal, homogenized [OPG study]3.8129511
GSM549105patient 128, normal, homogenized [OPG study]4.0180216
GSM549106patient 134, normal, homogenized [OPG study]3.70599
GSM549112patient 048, normal, homogenized [OPG study]3.8299111
GSM549125patient 011, cancer, homogenized [OPG study]3.8825713
GSM549127patient 024, cancer, homogenized [OPG study]3.8896614
GSM549135patient 035, cancer, homogenized [OPG study]3.7304210